100 BAMS Seats Still Vacant In Maharashtra
- byDoctor News Daily Team
- 23 July, 2025
- 0 Comments
- 0 Mins
Maharashtra: Even after UG AYUSH counselling process concluded in the state of Maharashtra, over 100 BAMS seats remain vacant.
Reports from media accounts suggest that around 100 BAMS seats are still vacant after the conclusion of the counselling process. BAMS is one of the preferred courses among the aspirants along with MBBS. There have been delays in approving extra seats and new college recognitions this academic year. Due to these delays, so many seats remain vacant, experts suggest.
Compared to the previous academic year, more colleges took part in the counselling process this academic year. This academic year more than 100 colleges took part in the counselling process. More than 7000 seats were available for BAMS this academic year.
Also Read:Applications Invited For Post-Doctoral Fellowship, Post-Doctoral Certificate Courses At GIPMER, details
The report from Free Press Journal suggests that as many as 11 Ayurveda Colleges were provided recognition in the month of November when almost the entire counselling process was already underway. After the admission deadline of 30th November 2023, a few colleges also got recognition.
An official from Maha CET Cell, while discussing with Indian Express, said, “The BAMS course does not see such vacancy, considering that this is the next best option for medicine aspirants, after MBBS. The number of seats increased; however, were included in admissions only much later in the process, due to which many candidates must have confirmed admissions in other courses.”
BAMS counselling in the state is conducted by Maha CET Cell. CAP stray vacancy round 5 was conducted in the month of November 2023. A total of 249 candidates were selected. The list was declared on 28th November 2023. The selected candidates were asked to report till 31st November 2023.
Also Read:JIPMER Invites Submission Of Proposals To Scientific Advisory Committee For January 2024
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!